This phenotype is clearly milder than the pharmacoresistant generalized epilepsy with tonic-clonic seizures with autosomal recessive inheritance associated with the HCN2 mutation (E515K) we previously reported (DiFrancesco et al., 2011). The gene discussed is HCN2; the disease is Bilateral tonic-clonic seizure.